Recurrent Kawasaki disease at a tertiary care center in Chandigarh, North West India: 24 years of clinical experience
暂无分享,去创建一个
[1] B. McCrindle,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association , 2017, Circulation.
[2] J. Newburger,et al. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population , 2016, Journal of the American Heart Association.
[3] R. Holman,et al. Recurrent Kawasaki disease: USA and Japan , 2015, Pediatrics international : official journal of the Japan Pediatric Society.
[4] Yun-Ching Fu,et al. Early Immunoglobulin Therapy and Outcomes in Kawasaki Disease , 2015, Medicine.
[5] D. Burgner,et al. The epidemiology of Kawasaki disease: a global update , 2015, Archives of Disease in Childhood.
[6] K. Kotani,et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. , 2015, Journal of epidemiology.
[7] Ya-li Liu,et al. Characteristics of Kawasaki Disease in Older Children , 2011, Clinical pediatrics.
[8] S. Balasubramanian,et al. Recurrent Kawasaki disease , 2009, Indian journal of pediatrics.
[9] F. Gong,et al. [Clinical features of recurrent Kawasaki disease in 20 children]. , 2008, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.
[10] K. Kayaba,et al. Increasing incidence of Kawasaki disease in Japan: Nationwide survey , 2008, Pediatrics international : official journal of the Japan Pediatric Society.
[11] R. Holman,et al. Analysis of Potential Risk Factors Associated With Nonresponse to Initial Intravenous Immunoglobulin Treatment Among Kawasaki Disease Patients in Japan , 2008, The Pediatric infectious disease journal.
[12] B. Mittal,et al. A comparison of the clinical profile of Kawasaki disease in children from Northern India above and below 5 years of age. , 2007, Clinical and experimental rheumatology.
[13] Junbao Du,et al. VALGANCICLOVIR FOR CONGENITAL CMV INFECTION: A PILOT STUDY ON PLASMA CONCENTRATION IN NEWBORNS AND INFANTS , 2007, The Pediatric infectious disease journal.
[14] C. Chiu,et al. Kawasaki disease in infants three months of age or younger. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[15] Jen-Her Lu,et al. Characteristics of Kawasaki Disease in Infants Younger than Six Months of Age , 2006, The Pediatric infectious disease journal.
[16] R. Holman,et al. Kawasaki Syndrome and Risk Factors for Coronary Artery Abnormalities: United States, 1994–2003 , 2006, The Pediatric infectious disease journal.
[17] B. Mittal,et al. Kawasaki Disease A Decade of Experience From North India , 2005 .
[18] H. Kim,et al. Clinical Characteristics of Recurrent Kawasaki Disease , 2004 .
[19] H. Yanagawa,et al. Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients. , 1998, Pediatrics.
[20] N. Curtis. Kawasaki disease , 1997, BMJ.
[21] K Hashino,et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.
[22] H. Yanagawa,et al. A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan , 1996, European Journal of Pediatrics.
[23] H. Yanagawa,et al. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. , 1995, Archives of pediatrics & adolescent medicine.
[24] H. Yanagawa,et al. Incidence rate of recurrent Kawasaki disease in Japan , 1994, Acta paediatrica.
[25] H. Yanagawa,et al. A nationwide incidence survey of Kawasaki disease in 1985-1986 in Japan. , 1988, The Journal of infectious diseases.
[26] R. Holman,et al. Kawasaki syndrome in the United States 1976 to 1980. , 1983, American journal of diseases of children.
[27] M. Melish. Kawasaki syndrome--United States. , 1983, MMWR. Morbidity and mortality weekly report.
[28] N. M. Osman. Recurrent Kawasaki disease resistant to initial treatment with intravenous immunoglobulin. , 2012, Sudanese journal of paediatrics.